Alhydrogel® adjuvant 2%
|Alhydrogel® adjuvant 2%||Unit size||Cat. code||Docs||Qty||Price|
Aluminum hydroxide gel
50 ml (5 x 10 ml)
Vaccine Adjuvant: Aluminium hydroxide gel
Alhydrogel® adjuvant 2%, referred to as alum, is an aluminum hydroxide wet gel suspension. Alum induces a Th2 response by improving the attraction and uptake of antigen by antigen-presenting cells (APCs). It can also activate innate immunity pathways triggered by pattern recognition receptors (PRRs).
In contrast to Adju-Phos®, Alhydrogel® particles have a net positive electrical charge at pH 5-7 and thus are well suited for adsorption of negatively charged antigens (e.g. antigens with isoelectric points below the pH of formulation).
Alhydrogel® adjuvant is sterilized by heating and aseptically filled.
InvivoGen products are for research purposes only; they are not for use in humans.
Alhydrogel® is a trademark that belongs to Croda and is registered in a large number of countries and regions worldwide.
Specificity: Th2 response
CAS number: 21645-51-2
Aluminum content: 9.0 – 11.0 mg/ml
- Alhydrogel® adjuvant 2% 50 ml (vac-alu-50) is aseptically refilled and repacked by InvivoGen from Croda's original material.
- Alhydrogel® adjuvant 2% 250 ml (vac-alu-250) is sterilized by heating and aseptically filled. It is tested for sterility and pyrogenicity by Croda.
Working concentration: 1:9 - 1:1 (Alhydrogel®:antigen).
The adsorption capacity for a model protein such as diphtheroid toxoid, human growth hormone, or ovalbumin in Alhydrogel® adjuvant varies from 1 to 3 (mg/mg Al).
Alhydrogel adjuvant 2% is available in two pack sizes:
- 50 ml (5 x 10 ml) Alhydrogel adjuvant 2%: vac-alu-50
- 250 ml Alhydrogel adjuvant 2%: vac-alu-250
Alhydrogel adjuvant 2% is provided as a ready-to-use, sterile wet gel suspension
Alhydrogel adjuvant 2% is shipped at room temperature.
Alhydrogel adjuvant 2% should be stored at room temperature.
DO NOT FREEZE.Back to the top
Alhydrogel adjuvant 2% is an aluminium hydroxide (referred to as alum) wet gel suspension. Alum acts primarily through the formation of a depot at the injection site, enabling enhanced antigen availability, activation of antigen presenting cells (APCs) and uptake by immune cells . It can also activate innate immunity pathways triggered by pattern recognition receptors (PRRs). The NLR pathway has been recently described as an important mechanism in alum adjuvancy . Alum has been shown to activate the NLRP3 inflammasome, although its role in alum-induced antibody response is controversial .
1. Morefield GL. et al., 2005. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23(13): 1588-95.
2. Li H. et al., 2008. Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol. 181(1):17-21.
3. Franchi L. & Nuñez G., 2008. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur. J. Immunol. 38(8):2085-9